Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Short-Term Debt repayments (2022 - 2026)

Viemed Healthcare filings provide 4 years of Short-Term Debt repayments readings, the most recent being $8.0 million for Q4 2025.

  • On a quarterly basis, Short-Term Debt repayments changed N/A to $8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.1 million, a 162.26% increase, with the full-year FY2025 number at $13.0 million, up 160.0% from a year prior.
  • Short-Term Debt repayments hit $8.0 million in Q4 2025 for Viemed Healthcare, up from $113000.0 in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $8.0 million in Q4 2025 to a low of -$872000.0 in Q3 2022.
  • Median Short-Term Debt repayments over the past 4 years was $1.0 million (2023), compared with a mean of $2.1 million.
  • Biggest five-year swings in Short-Term Debt repayments: surged 558.72% in 2023 and later plummeted 158.61% in 2024.
  • Viemed Healthcare's Short-Term Debt repayments stood at -$872000.0 in 2022, then soared by 329.36% to $2.0 million in 2023, then surged by 150.0% to $5.0 million in 2024, then surged by 60.0% to $8.0 million in 2025.
  • The last three reported values for Short-Term Debt repayments were $8.0 million (Q4 2025), $113000.0 (Q1 2025), and $5.0 million (Q3 2024) per Business Quant data.